Recruiting soon

PICCOLETO-XIImpact of Aggressive vs Standard Lesion Preparation on Drug-coated Balloon Angioplasty for In-stent Restenosis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This observational study aims to compare the impact of aggressive versus standard lesion preparation on drug-coated balloon angioplasty for in-stent restenosis, specifically focusing on the occurrence of major adverse cardiovascular events such as cardiac death, non-fatal myocardial infarction, or target lesion revascularization.

What is being collected

Data Collection

Collected from past medical records and data - Retrospective
Who is being recruted

Arterial Occlusive Diseases+5

+ Arteriosclerosis

+ Cardiovascular Diseases

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: June 2026
See protocol details

Summary

Principal SponsorFondazione Ricerca e Innovazione Cardiovascolare ETS
Study ContactFilippo Luca Gurgoglione, MD, PhDMore contacts
Last updated: February 6, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2026

Actual date on which the first participant was enrolled.

The PICCOLETO XI A-PREP study focuses on understanding the impact of different lesion preparation strategies used before drug-coated balloon (DCB) angioplasty for in-stent restenosis (ISR). In-stent restenosis is a condition where a previously placed stent narrows again, posing a significant challenge. The DCB angioplasty is a treatment method that doesn't involve adding more metal layers, which could be beneficial. The study emphasizes the importance of proper lesion preparation for better drug delivery and reduced risk of restenosis. It involves patients who will be grouped based on their lesion preparation strategy, either aggressive or standard. The aggressive approach uses tools like cutting, scoring, or specific types of balloons, while the standard approach uses semi-compliant or non-compliant balloons. The study aims to improve care for those with in-stent restenosis by finding the best preparation method. During the study, participants will undergo their assigned preparation strategy and subsequent DCB angioplasty. The results will be measured based on Major Adverse Cardiovascular Events (MACE), which is a combination of three potential outcomes: cardiac death, non-fatal heart attack, or the need for another procedure on the same treated area. These outcomes will be assessed at one year and the longest available follow-up period. The study's findings could provide insights into the most effective and safe preparation strategies for in-stent restenosis treatment.

Official TitleImpact of Lesion PREParation With Modifying Balloons During Drug-coated Balloon (DCB) Angioplasty for In-stent Restenosis (ISR) - PICCOLETO XI A-PREP Study
Principal SponsorFondazione Ricerca e Innovazione Cardiovascolare ETS
Study ContactFilippo Luca Gurgoglione, MD, PhDMore contacts
Last updated: February 6, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

500 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Arterial Occlusive DiseasesArteriosclerosisCardiovascular DiseasesCoronary Artery DiseaseCoronary DiseaseHeart DiseasesVascular DiseasesMyocardial Ischemia

Criteria

2 inclusion criteria required to participate
Adult patients ≥18 years of age

Patients who underwent DCB angioplasty for in-stent restenosis

1 exclusion criteria prevent from participating
Lack of clinical outcome assessment

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers